NEW YORK (Reuters) - Americans' low use of healthcare services has proved a boon to health insurers over the past two years, reducing medical claim costs and raising profits. The growing view on Wall Street is that those days are over.
NEW YORK (Reuters) - Americans' low use of healthcare services has proved a boon to health insurers over the past two years, reducing medical claim costs and raising profits. The growing view on Wall Street is that those days are over.
Friday, 18 May 2012 | Source: The Associated Press
Shares of medical test maker Sequenom fell Friday, a day after the company announced that insurer Coventry Health Care Inc. would no longer pay for the company's Down syndrome test for pregnant women.
Expecting Aetna and UnitedHealth to beat Wall Street estimates as health insurers kick off fourth-quarter earnings, senior analyst Peter Costa of Wells Fargo says these companies will continue their winning streak in 2012, due to rising costs, lower unemployment and even health-care reform... Read More